Papers Tagged ‘HFPEF’

Distinct Hemodynamic Changes After Interventional Mitral Valve Edge-to-Edge Repair in Different Phenotypes of Heart Failure: An Integrated Hemodynamic Analysis

B Schrage, D Kalbacher, M Schwarzl, N Rubsamen, C Waldeyer, PM Becher, E Tigges, D Burkhoff, S Blankenberg, E Lubos, U Schafer and D Westermann
J Am Heart Assoc 2018;7

Download Full Paper

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial

T Feldman, L Mauri, R Kahwash, S Litwin, MJ Ricciardi, P van der Harst, M Penicka, PS Fail, DM Kaye, MC Petrie, A Basuray, SL Hummel, R Forde-McLean, CD Nielsen, S Lilly, JM Massaro, D Burkhoff, SJ Shah and REDUCE LAP-HF I Investigators and Study Coordinators
Circulation 2018;137:364-375

Download Full Paper

Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction

DM Kaye, FE Silvestry, F Gustafsson, JG Cleland, DJ van Veldhuisen, P Ponikowski, J Komtebedde, S Nanayakkara, D Burkhoff and SJ Shah
Eur J Heart Fail 2017;19:1690-1697

Download Full Paper

Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction

E Wolsk, D Kaye, BA Borlaug, D Burkhoff, DW Kitzman, J Komtebedde, CSP Lam, P Ponikowski, SJ Shah and F Gustafsson
Eur J Heart Fail 2018;20:715-722

Download Full Paper

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial

G Hasenfuss, C Hayward, D Burkhoff, FE Silvestry, S McKenzie, F Gustafsson, F Malek, J Van der Heyden, I Lang, MC Petrie, JG Cleland, M Leon and DM Kaye
Lancet 2016;387:1298-1304

Download Full Paper

Page 1 of 41234